Selbyville, DE -- (SBWIRE) -- 01/02/2019 -- Global Autoimmune Disease Diagnostics Market is set to exceed USD 16 billion by 2024; according to a new research report by Global Market Insights, Inc.

Rising prevalence of autoimmune disorders such as rheumatoid arthritis, Hashimoto's thyroiditis, type 1 diabetes and Grave's disease will drive the global autoimmune disease diagnostics market. Growing patient awareness levels pertaining to autoimmune diseases due to the launch of national awareness campaigns will further fuel industry expansion.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/618

Presence of favorable government initiatives such as The Cooperative Study Group for Autoimmune Disease Prevention (CSGADP) and NIH's HLA Region Genetics in Immune-Mediated Diseases Consortium for autoimmune diseases diagnosis and treatment will augment industry growth.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Bio-Rad Laboratories
- bioMérieux
- Roche Diagnostics Middle East
- Quest Diagnostics
- Beckman Coulter
- SQI Diagnostics
- Inova Diagnostics
- A Werfen Company

Lack of skilled healthcare professionals and experts coupled with long and complex diagnosis process for autoimmune disease will hamper business growth. Low lab automation rate leads to increasing diagnosis turnaround time which further impedes the market growth.

Localized autoimmune disease diagnostics held higher market share in 2016 and should show a similar trend over the forecast years owing to the increasing prevalence of gastrointestinal autoimmune diseases such as Crohn's disease, Grave's disease and multiple sclerosis affecting the specific organ. Systemic disease diagnostics is poised to be the fastest growing segment with a CAGR of 3.9% owing to rising cases of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) across the globe.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/618

UK autoimmune disease diagnostics market should witness considerable growth over the coming years. Increasing prevalence of systemic disorders such as rheumatoid arthritis coupled with improving public awareness levels through efforts of organizations such as National Rheumatoid Arthritis Society (NRAS) should augment regional growth.

China autoimmune disease diagnostic market should grow at robust rate with growing prevalence of autoimmune pancreatitis, improving healthcare infrastructure coupled with increased R&D efforts and rising patient awareness levels.

Autoimmune disease diagnostics market by product
o Systemic autoimmune disease diagnostics
o Rheumatoid arthritis diagnostics
o Ankylosing spondylitis diagnostics
o Systemic lupus erythematosus diagnostics
o Localized disease diagnostics